annual CFF:
$5.37M+$5.46M(+6065.56%)Summary
- As of today (June 17, 2025), NAGE annual cash flow from financing activities is $5.37 million, with the most recent change of +$5.46 million (+6065.56%) on December 1, 2024.
- During the last 3 years, NAGE annual CFF has fallen by -$30.73 million (-85.12%).
- NAGE annual CFF is now -89.03% below its all-time high of $48.95 million, reached on December 1, 2017.
Performance
NAGE Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$3.10M-$643.00K(-17.16%)Summary
- As of today (June 17, 2025), NAGE quarterly cash flow from financing activities is $3.10 million, with the most recent change of -$643.00 thousand (-17.16%) on March 1, 2025.
- Over the past year, NAGE quarterly CFF has increased by +$3.12 million (+22278.57%).
- NAGE quarterly CFF is now -90.72% below its all-time high of $33.45 million, reached on March 1, 2021.
Performance
NAGE quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$8.49M+$3.12M(+58.09%)Summary
- As of today (June 17, 2025), NAGE TTM cash flow from financing activities is $8.49 million, with the most recent change of +$3.12 million (+58.09%) on March 1, 2025.
- Over the past year, NAGE TTM CFF has increased by +$8.59 million (+8340.78%).
- NAGE TTM CFF is now -82.66% below its all-time high of $48.95 million, reached on December 1, 2017.
Performance
NAGE TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
NAGE Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6065.6% | +10000.0% | +8340.8% |
| 3 y3 years | -85.1% | +10000.0% | +220.8% |
| 5 y5 years | -68.2% | +8291.9% | -40.6% |
NAGE Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -85.1% | +6065.6% | -59.6% | +4185.5% | at high | +8340.8% |
| 5 y | 5-year | -85.1% | +6065.6% | -90.7% | +4185.5% | -79.8% | +8340.8% |
| alltime | all time | -89.0% | +6065.6% | -90.7% | +1365.8% | -82.7% | +8340.8% |
NAGE Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $3.10M(-17.2%) | $8.49M(+58.1%) |
| Dec 2024 | $5.37M(-6065.6%) | $3.75M(+260.7%) | $5.37M(+247.5%) |
| Sep 2024 | - | $1.04M(+74.3%) | $1.54M(+207.2%) |
| Jun 2024 | - | $596.00K(-4357.1%) | $503.00K(-588.3%) |
| Mar 2024 | - | -$14.00K(-81.6%) | -$103.00K(+14.4%) |
| Dec 2023 | -$90.00K(-101.2%) | -$76.00K(+2433.3%) | -$90.00K(-101.2%) |
| Sep 2023 | - | -$3000.00(-70.0%) | $7.67M(+0.2%) |
| Jun 2023 | - | -$10.00K(+900.0%) | $7.65M(-0.1%) |
| Mar 2023 | - | -$1000.00(-100.0%) | $7.66M(+0.0%) |
| Dec 2022 | $7.65M(-78.8%) | $7.68M(<-9900.0%) | $7.65M(>+9900.0%) |
| Sep 2022 | - | -$18.00K(+350.0%) | $38.00K(-90.4%) |
| Jun 2022 | - | -$4000.00(+33.3%) | $395.00K(-85.1%) |
| Mar 2022 | - | -$3000.00(-104.8%) | $2.65M(-92.7%) |
| Dec 2021 | $36.09M(+317.3%) | $63.00K(-81.4%) | $36.09M(-3.0%) |
| Sep 2021 | - | $339.00K(-84.9%) | $37.21M(-0.4%) |
| Jun 2021 | - | $2.25M(-93.3%) | $37.37M(-11.2%) |
| Mar 2021 | - | $33.45M(+2731.9%) | $42.06M(+386.2%) |
| Dec 2020 | $8.65M(-48.8%) | $1.18M(+140.0%) | $8.65M(+11.8%) |
| Sep 2020 | - | $492.00K(-92.9%) | $7.74M(-45.8%) |
| Jun 2020 | - | $6.94M(>+9900.0%) | $14.28M(-15.3%) |
| Mar 2020 | - | $37.00K(-86.3%) | $16.87M(-0.1%) |
| Dec 2019 | $16.88M(<-9900.0%) | $271.00K(-96.1%) | $16.88M(+1.9%) |
| Sep 2019 | - | $7.04M(-26.1%) | $16.57M(+71.2%) |
| Jun 2019 | - | $9.52M(>+9900.0%) | $9.68M(+5694.6%) |
| Mar 2019 | - | $55.00K(-227.9%) | $167.00K(-285.6%) |
| Dec 2018 | -$90.00K(-100.2%) | -$43.00K(-130.3%) | -$90.00K(-100.4%) |
| Sep 2018 | - | $142.00K(+992.3%) | $25.40M(-15.9%) |
| Jun 2018 | - | $13.00K(-106.4%) | $30.22M(-38.1%) |
| Mar 2018 | - | -$202.00K(-100.8%) | $48.81M(-0.3%) |
| Dec 2017 | $48.95M(+6389.3%) | $25.45M(+413.1%) | $48.95M(+110.4%) |
| Sep 2017 | - | $4.96M(-73.3%) | $23.26M(+28.8%) |
| Jun 2017 | - | $18.60M(<-9900.0%) | $18.06M(+5530.8%) |
| Mar 2017 | - | -$60.00K(-74.4%) | $320.70K(-57.5%) |
| Dec 2016 | $754.30K | -$234.60K(-4.4%) | $754.20K(-74.7%) |
| Sep 2016 | - | -$245.30K(-128.5%) | $2.98M(-6.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2016 | - | $860.60K(+130.4%) | $3.18M(-33.3%) |
| Mar 2016 | - | $373.50K(-81.3%) | $4.77M(+9.9%) |
| Dec 2015 | $4.34M(+61.3%) | $1.99M(-4888.7%) | $4.34M(-7.9%) |
| Sep 2015 | - | -$41.60K(-101.7%) | $4.72M(-7.8%) |
| Jun 2015 | - | $2.45M(-4391.4%) | $5.12M(+93.7%) |
| Mar 2015 | - | -$57.10K(-102.4%) | $2.64M(-1.9%) |
| Dec 2014 | $2.69M(-42.1%) | $2.37M(+558.0%) | $2.69M(-17.7%) |
| Sep 2014 | - | $359.70K(-1442.2%) | $3.27M(+13.1%) |
| Jun 2014 | - | -$26.80K(+332.3%) | $2.89M(-26.6%) |
| Mar 2014 | - | -$6200.00(-100.2%) | $3.94M(-15.2%) |
| Dec 2013 | $4.65M(-54.8%) | $2.95M(<-9900.0%) | $4.65M(+166.3%) |
| Sep 2013 | - | -$19.60K(-101.9%) | $1.75M(-6.1%) |
| Jun 2013 | - | $1.02M(+46.0%) | $1.86M(+96.1%) |
| Mar 2013 | - | $699.80K(+1505.0%) | $948.00K(-90.8%) |
| Dec 2012 | $10.30M(+317.0%) | $43.60K(-53.6%) | $10.30M(+0.7%) |
| Sep 2012 | - | $93.90K(-15.2%) | $10.23M(-12.1%) |
| Jun 2012 | - | $110.70K(-98.9%) | $11.63M(-3.4%) |
| Mar 2012 | - | $10.05M(<-9900.0%) | $12.04M(+387.5%) |
| Dec 2011 | $2.47M(-46.5%) | -$23.80K(-101.6%) | $2.47M(-5.9%) |
| Sep 2011 | - | $1.50M(+190.1%) | $2.63M(+134.0%) |
| Jun 2011 | - | $515.80K(+7.3%) | $1.12M(-78.0%) |
| Mar 2011 | - | $480.70K(+264.2%) | $5.11M(+10.6%) |
| Dec 2010 | $4.62M(-5980.0%) | $132.00K(-2013.0%) | $4.62M(+3.3%) |
| Sep 2010 | - | -$6900.00(-100.2%) | $4.47M(+0.3%) |
| Jun 2010 | - | $4.50M(<-9900.0%) | $4.45M(-6572.5%) |
| Mar 2010 | - | -$10.50K(-34.8%) | -$68.80K(-12.2%) |
| Dec 2009 | -$78.50K(-102.4%) | -$16.10K(-24.8%) | -$78.40K(+25.8%) |
| Sep 2009 | - | -$21.40K(+2.9%) | -$62.30K(+52.3%) |
| Jun 2009 | - | -$20.80K(+3.5%) | -$40.90K(+103.5%) |
| Mar 2009 | - | -$20.10K(<-9900.0%) | -$20.10K(-2333.3%) |
| Dec 2008 | $3.24M(>+9900.0%) | - | - |
| Feb 2008 | - | $0.00(0.0%) | $900.00(0.0%) |
| Nov 2007 | $900.00 | $0.00(0.0%) | $900.00(0.0%) |
| Aug 2007 | - | $0.00(-100.0%) | $900.00(0.0%) |
| May 2007 | - | $900.00(>+9900.0%) | $900.00(>+9900.0%) |
| Feb 2007 | - | $0.00 | $0.00 |
FAQ
- What is Niagen Bioscience annual cash flow from financing activities?
- What is the all time high annual CFF for Niagen Bioscience?
- What is Niagen Bioscience annual CFF year-on-year change?
- What is Niagen Bioscience quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Niagen Bioscience?
- What is Niagen Bioscience quarterly CFF year-on-year change?
- What is Niagen Bioscience TTM cash flow from financing activities?
- What is the all time high TTM CFF for Niagen Bioscience?
- What is Niagen Bioscience TTM CFF year-on-year change?
What is Niagen Bioscience annual cash flow from financing activities?
The current annual CFF of NAGE is $5.37M
What is the all time high annual CFF for Niagen Bioscience?
Niagen Bioscience all-time high annual cash flow from financing activities is $48.95M
What is Niagen Bioscience annual CFF year-on-year change?
Over the past year, NAGE annual cash flow from financing activities has changed by +$5.46M (+6065.56%)
What is Niagen Bioscience quarterly cash flow from financing activities?
The current quarterly CFF of NAGE is $3.10M
What is the all time high quarterly CFF for Niagen Bioscience?
Niagen Bioscience all-time high quarterly cash flow from financing activities is $33.45M
What is Niagen Bioscience quarterly CFF year-on-year change?
Over the past year, NAGE quarterly cash flow from financing activities has changed by +$3.12M (+22278.57%)
What is Niagen Bioscience TTM cash flow from financing activities?
The current TTM CFF of NAGE is $8.49M
What is the all time high TTM CFF for Niagen Bioscience?
Niagen Bioscience all-time high TTM cash flow from financing activities is $48.95M
What is Niagen Bioscience TTM CFF year-on-year change?
Over the past year, NAGE TTM cash flow from financing activities has changed by +$8.59M (+8340.78%)